Treeline Biosciences is a cutting-edge biotech brand focused on scientific innovation for the benefit of patients with cancer and other serious diseases. With a dedicated team of over 130 experts in biology, chemistry, protein sciences, and computation, Treeline is committed to making significant progress in drug discovery and development. They have established a strong internal research and development team, complemented by external partnerships for scalability and specialized capabilities.

Treeline's approach to portfolio construction and team building is backed by a recent expansion of investor support, including significant capital commitment from KKR's Health Care Strategic Growth Fund II. This funding ensures Treeline has the resources and runway needed for both long-term projects and immediate opportunities. Treeline's vision is driven by their mission to provide scientific breakthroughs with clear implications for patients, and they continue to attract top talent and make long-term commitments to their projects.

Treeline Biosciences is dedicated to shaping the future of healthcare through scientific excellence